Cargando…
Prospective approaches to enhancing CAR T cell therapy for glioblastoma
Glioblastoma (GBM) is the most common malignant brain tumor. The poor clinical outcome and overall ineffectiveness of current standard treatments, including surgery, chemotherapy, and radiation, highlight the urgent need for alternative tumor-specific therapies for GBM. Chimeric antigen receptor (CA...
Autores principales: | Choi, Sun Il, Yin, Jinlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582117/ https://www.ncbi.nlm.nih.gov/pubmed/36275671 http://dx.doi.org/10.3389/fimmu.2022.1008751 |
Ejemplares similares
-
Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021) -
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture
por: Ponterio, Eleonora, et al.
Publicado: (2020) -
CAR T Cell Therapy for Neuroblastoma
por: Richards, Rebecca M., et al.
Publicado: (2018) -
CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
por: Thomas, Simone, et al.
Publicado: (2023) -
Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance
por: Qin, Yue, et al.
Publicado: (2022)